| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.15▲ | 27.76▲ | 27.76▲ | 27.70▲ | 27.05▲ |
| MA10 | 27.58▲ | 27.18▲ | 27.27▲ | 27.51▲ | 25.19▲ |
| MA20 | 27.22▲ | 27.47▲ | 27.40▲ | 27.21▲ | 27.07▲ |
| MA50 | 27.51▲ | 27.34▲ | 27.23▲ | 24.92▲ | 30.01▼ |
| MA100 | 27.28▲ | 26.31▲ | 25.48▲ | 27.66▲ | N/A |
| MA200 | 25.77▲ | 25.05▲ | 24.95▲ | 32.00▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.204▲ | 0.136▲ | 0.099▲ | -0.066▼ | 0.152▲ |
| RSI | 58.817▲ | 58.700▲ | 57.619▲ | 57.582▲ | 51.452▲ |
| STOCH | 96.456▲ | 73.165 | 64.169 | 45.688 | 57.590 |
| WILL %R | 0.000▲ | 0.000▲ | -32.506 | -48.090 | -64.109 |
| CCI | 108.481▲ | 145.742▲ | 90.181 | -30.243 | 68.435 |
|
Friday, April 17, 2026 01:22 PM
Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is ...
|
|
Tuesday, March 17, 2026 01:30 PM
FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/04/26 | 25.82 | 28.49 | 25.82 | 27.81 | 35,618 |
| 27/04/26 | 26.49 | 28.00 | 25.95 | 27.65 | 28,555 |
| 24/04/26 | 28.50 | 28.50 | 27.00 | 27.35 | 15,306 |
| 23/04/26 | 29.26 | 29.26 | 26.93 | 27.27 | 10,750 |
| 22/04/26 | 27.85 | 29.18 | 27.75 | 28.43 | 33,727 |
| 21/04/26 | 27.40 | 27.40 | 26.76 | 27.15 | 17,314 |
| 20/04/26 | 27.44 | 27.615 | 26.52 | 26.98 | 21,812 |
| 17/04/26 | 27.70 | 28.61 | 27.05 | 27.15 | 48,404 |
| 16/04/26 | 27.38 | 28.70 | 27.38 | 27.80 | 27,018 |
| 15/04/26 | 28.895 | 29.0215 | 26.0001 | 27.50 | 32,880 |
|
|
||||
|
|
||||
|
|